EverSource Wealth Advisors LLC Sells 737 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

EverSource Wealth Advisors LLC cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.9% in the fourth quarter, Holdings Channel.com reports. The firm owned 3,910 shares of the financial services provider’s stock after selling 737 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in iShares Biotechnology ETF were worth $531,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in IBB. Crewe Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after buying an additional 78 shares during the period. Nemes Rush Group LLC bought a new stake in shares of iShares Biotechnology ETF during the fourth quarter worth $322,000. Milestone Investment Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 412.3% during the fourth quarter. Milestone Investment Advisors LLC now owns 4,621 shares of the financial services provider’s stock valued at $628,000 after purchasing an additional 3,719 shares during the period. Corient Private Wealth LLC grew its holdings in shares of iShares Biotechnology ETF by 1.0% in the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after purchasing an additional 841 shares during the last quarter. Finally, Gladstone Institutional Advisory LLC increased its stake in iShares Biotechnology ETF by 7.1% in the 4th quarter. Gladstone Institutional Advisory LLC now owns 6,316 shares of the financial services provider’s stock worth $858,000 after buying an additional 420 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock traded down $1.27 during trading hours on Thursday, hitting $136.62. The company had a trading volume of 356,107 shares, compared to its average volume of 1,714,835. The company has a 50-day moving average price of $132.76 and a two-hundred day moving average price of $131.80. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a dividend of $0.126 per share. This represents a $0.50 dividend on an annualized basis and a yield of 0.37%. The ex-dividend date of this dividend was Thursday, March 21st.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.